Literature DB >> 24869759

TCF4 silencing sensitizes the colon cancer cell line to oxaliplatin as a common chemotherapeutic drug.

Fatemeh Gheidari1, Behnaz Bakhshandeh, Ladan Teimoori-Toolabi, Amirhosein Mehrtash, Mahdis Ghadir, Sirous Zeinali.   

Abstract

Colon cancer is among the most prevalent cancers worldwide. Although the main modality of treatment is surgery, resistance to chemoradiotherapy raises concerns. Hence, we aimed to determine the effect of RNA-mediated silencing of tcf4, the downstream effector of the wnt signaling pathway, on the response of the SW480 cell line to oxaliplatin, a common chemotherapeutic drug. For this, two different silencing sequences against TCF4 mRNA were selected and cloned into pSilencer neo2.1. The SW480 cell line was stably transfected with the silencing constructs (namely p1396, p1874, and p silencer containing a scrambled sequence) and labeled SW1396, SW1874, and SW-Sc, respectively. Subsequently, the effect of oxaliplatin (from 0 to 11.25 μmol/l) on these cells was studied using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide proliferation assay. Suppression of tcf4 expression in stable transfected cells with p1396 and p1874 was confirmed by quantitative reverse transcription-PCR and western blot analysis. Although oxaliplatin was not toxic to SW480 and SW-sc in the range tested, in SW1396 and SW1874 cells, a toxic effect was evident at 3.75 and 4.375 μmol/l. Also, SW1396 and SW1874 cells appeared to have a round shape in comparison with SW480 and SW-Sc cells. Only for SW1396, the number of apoptotic cells was significantly different before and after the addition of oxaliplatin (LC50 of oxaliplatin). The proliferating cells in SW480, SW1874, and SW-Sc increased after treatment with oxaliplatin; however, this was not observed in SW1396. Although silencing the tcf4 gene would confer sensitivity to oxaliplatin in SW1874 and especially SW1396, in SW480 and SW-Sc, the lethal effect of oxaliplatin was compensated by its effect in increasing the proliferation of cells. This sensitization effect may be because of different mechanisms including TCF4 motifs in the ABCB1 promoter or defects in nucleotide excision repair or double-strand break repair systems after tcf4 silencing.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24869759     DOI: 10.1097/CAD.0000000000000118

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  5 in total

Review 1.  Precise and efficient siRNA design: a key point in competent gene silencing.

Authors:  E Fakhr; F Zare; L Teimoori-Toolabi
Journal:  Cancer Gene Ther       Date:  2016-03-18       Impact factor: 5.987

2.  A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells.

Authors:  Yanyuan Wu; Trinh Tran; Sami Dwabe; Marianna Sarkissyan; Juri Kim; Miguel Nava; Sheilah Clayton; Richard Pietras; Robin Farias-Eisner; Jaydutt V Vadgama
Journal:  Breast Cancer Res Treat       Date:  2017-03-23       Impact factor: 4.872

3.  Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review).

Authors:  Gui-Xian Zhu; Dian Gao; Zhao-Zhao Shao; Li Chen; Wen-Jie Ding; Qiong-Fang Yu
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

Review 4.  Mechanisms of Immune Escape and Resistance to Checkpoint Inhibitor Therapies in Mismatch Repair Deficient Metastatic Colorectal Cancers.

Authors:  Vito Amodio; Gianluca Mauri; Nicole M Reilly; Andrea Sartore-Bianchi; Salvatore Siena; Alberto Bardelli; Giovanni Germano
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

Review 5.  Epithelial-Mesenchymal Transition and Breast Cancer.

Authors:  Yanyuan Wu; Marianna Sarkissyan; Jaydutt V Vadgama
Journal:  J Clin Med       Date:  2016-01-26       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.